8-KItem 2.02 · Results of OperationsItem 7.01 · Reg FD DisclosureItem 9.01 · Financial Statements
Bristol-Myers Squibb ($BMY) filed an 8-K (Item 9.01) on Feb 5, 2026 furnishing a press release (Exhibit…
Filed with the SEC on · Summarized by InvestorsBot
Bristol-Myers Squibb ($BMY) filed an 8-K (Item 9.01) on Feb 5, 2026 furnishing a press release (Exhibit 99.1) and presentation materials (Exhibit 99.2). 📄🧾 #8K #SEC #BMY
The filing also includes the cover page in Inline XBRL (Exhibit 104). Signed by Corporate Secretary Amy Fallone, dated Feb 5, 2026. 📊 $BMY #8K #SEC
Press release & presentation are furnished—review Exhibits 99.1/99.2 on SEC EDGAR or company site for any material updates. 🔎 $BMY #8K #SEC